ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma

被引:130
作者
De Paepe, P
Baens, M
van Krieken, H
Verhasselt, B
Stul, M
Simons, A
Poppe, B
Laureys, G
Brons, P
Vandenberghe, P
Speleman, F
Praet, M
De Wolf-Peeters, C
Marynen, P
Wlodarska, I
机构
[1] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium
[2] Catholic Univ Louvain, Interuniv Inst Biotechnol, Div Morphol & Mol Pathol, B-3000 Louvain, Belgium
[3] Ghent Univ Hosp, Ctr Med Genet & Pediat Oncol, Dept Pathol, Ghent, Belgium
[4] Ghent Univ Hosp, Ctr Med Genet & Pediat Oncol, Dept Clin Chem, Ghent, Belgium
[5] Ghent Univ Hosp, Ctr Med Genet & Pediat Oncol, Dept Microbiol & Immunol, Ghent, Belgium
[6] Ghent Univ Hosp, Ctr Med Genet & Pediat Oncol, Dept Mol Diagnost, Ghent, Belgium
[7] Univ Nijmegen, Ctr Med, Dept Pathol, Nijmegen, Netherlands
[8] Univ Nijmegen, Ctr Med, Dept Human Genet, Nijmegen, Netherlands
[9] Univ Nijmegen, Ctr Med, Dept Pediat Oncol, Nijmegen, Netherlands
关键词
D O I
10.1182/blood-2003-04-1050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present 3 cases of large B-cell lymphoma (LBCL) with a granular cytoplasmic staining for anaplastic lymphoma kinase (ALK). All of the cases showed striking similarities in morphology and immunohistochemical profile characterized by a massive monomorphic proliferation of CD20(-)/CD138(+) plasmablast-like cells. In one of the cases, initially diagnosed as a null-type anaplastic large cell lymphoma (ALCL), the B-cell phenotype became evident only at recurrence. Fluorescent in situ hybridization (FISH) and molecular studies led to the detection of a CLTC-ALK rearrangement in all 3 cases, without any evidence of full-length ALK receptor expression. The associated t(2;17)(p23;q23) was demonstrated in the karyotype of 2 cases. Although a similar CLTC-ALK aberration was previously identified in ALK-positive T-/null cell ALCL and inflammatory myofibroblastic tumor, its association with ALK-positive LBCL seems to be specific and intriguing. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:2638 / 2641
页数:4
相关论文
共 24 条
[1]   Detection of the t(2;5)(p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma [J].
Arber, DA ;
Sun, LH ;
Weiss, LM .
HUMAN PATHOLOGY, 1996, 27 (06) :590-594
[2]   Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor [J].
Bridge, JA ;
Kanamori, M ;
Ma, ZG ;
Pickering, D ;
Hill, DA ;
Lydiatt, W ;
Lui, MY ;
Colleoni, GWB ;
Antonescu, CR ;
Ladanyi, M ;
Morris, SW .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) :411-415
[3]   NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors [J].
Chiarle, R ;
Gong, JZ ;
Guasparri, I ;
Pesci, A ;
Cai, J ;
Liu, J ;
Simmons, WJ ;
Dhall, G ;
Howes, J ;
Piva, R ;
Inghirami, G .
BLOOD, 2003, 101 (05) :1919-1927
[4]   Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor [J].
Cools, J ;
Wlodarska, I ;
Somers, R ;
Mentens, N ;
Pedeutour, F ;
Maes, B ;
De Wolf-Peeters, C ;
Pauwels, P ;
Hagemeijer, A ;
Marynen, P .
GENES CHROMOSOMES & CANCER, 2002, 34 (04) :354-362
[5]   A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation [J].
Delsol, G ;
Lamant, L ;
Mariame, B ;
Pulford, K ;
Dastugue, N ;
Brousset, P ;
RigalHuguet, F ;
AlSaati, T ;
Cerretti, DP ;
Morris, SW ;
Mason, DY .
BLOOD, 1997, 89 (05) :1483-1490
[6]  
Dierlamm J, 1996, GENE CHROMOSOME CANC, V16, P261, DOI 10.1002/(SICI)1098-2264(199608)16:4<261::AID-GCC6>3.0.CO
[7]  
2-W
[8]   MOLECULAR-DETECTION OF THE (2-5) TRANSLOCATION OF NON-HODGKINS-LYMPHOMA BY REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION [J].
DOWNING, JR ;
SHURTLEFF, SA ;
ZIELENSKA, M ;
CURCIOBRINT, AM ;
BEHM, FG ;
HEAD, DR ;
SANDLUND, JT ;
WEISENBURGER, DD ;
KOSSAKOWSKA, AE ;
THORNER, P ;
LORENZANA, A ;
LADANYI, M ;
MORRIS, SW .
BLOOD, 1995, 85 (12) :3416-3422
[9]   Translocations involving anaplastic lymphoma kinase (ALK) [J].
Duyster, J ;
Bai, RY ;
Morris, SW .
ONCOGENE, 2001, 20 (40) :5623-5637
[10]  
Falini B, 1999, BLOOD, V94, P3509